Lexaria Bioscience CORP. (LEXX) — DEF 14A Filings

All DEF 14A filings from Lexaria Bioscience CORP.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (3)

Lexaria Bioscience Sets Jan 27 Shareholder Meeting; Board, Auditor Votes Loom — Dec 10, 2025 Risk: low
Lexaria Bioscience Corp. (LEXX) is holding its 2026 Annual Shareholder Meeting on January 27, 2026, via Event Conferencing, where shareholders will vote on the
Lexaria Bioscience Files Definitive Proxy Statement — Nov 27, 2024 Risk: low
Lexaria Bioscience Corp. filed a definitive proxy statement (DEF 14A) on November 27, 2024, for its annual meeting on January 14, 2025. The company, incorporate
Lexaria Bioscience Corp. Announces 2024 Annual Shareholder Meeting Details — Mar 6, 2024 Risk: low
Lexaria Bioscience Corp. (LEXX) filed a Proxy Statement (DEF 14A) with the SEC on March 6, 2024. Lexaria Bioscience Corp. will hold its 2024 annual shareholder

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX